506235 Stock Overview
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API).
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Alembic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹91.25 |
| 52 Week High | ₹107.50 |
| 52 Week Low | ₹59.87 |
| Beta | 1.14 |
| 1 Month Change | 13.50% |
| 3 Month Change | -3.41% |
| 1 Year Change | 49.13% |
| 3 Year Change | -17.23% |
| 5 Year Change | 116.75% |
| Change since IPO | 2,005.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506235 | IN Real Estate | IN Market | |
|---|---|---|---|
| 7D | -5.1% | -3.2% | -2.5% |
| 1Y | 49.1% | 108.1% | 44.5% |
Return vs Industry: 506235 underperformed the Indian Real Estate industry which returned 107.9% over the past year.
Return vs Market: 506235 exceeded the Indian Market which returned 45.3% over the past year.
Price Volatility
| 506235 volatility | |
|---|---|
| 506235 Average Weekly Movement | 6.4% |
| Real Estate Industry Average Movement | 7.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 506235 has not had significant price volatility in the past 3 months.
Volatility Over Time: 506235's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1907 | 271 | Malika Amin | www.alembiclimited.com |
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties.
Alembic Limited Fundamentals Summary
| 506235 fundamental statistics | |
|---|---|
| Market cap | ₹23.43b |
| Earnings (TTM) | ₹2.45b |
| Revenue (TTM) | ₹1.46b |
9.6x
P/E Ratio16.1x
P/S RatioIs 506235 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506235 income statement (TTM) | |
|---|---|
| Revenue | ₹1.46b |
| Cost of Revenue | ₹525.10m |
| Gross Profit | ₹930.62m |
| Other Expenses | -₹1.52b |
| Earnings | ₹2.45b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.53 |
| Gross Margin | 63.93% |
| Net Profit Margin | 168.11% |
| Debt/Equity Ratio | 0.2% |
How did 506235 perform over the long term?
See historical performance and comparison